Improved Vaccine Technologies and Increased Preventive Measures Fuel Veterinary Vaccines Market

New Vaccines that include individual antigens are purer, cleaner, safer and generate a more focused and effective immune response than earlier vaccines.

Application of genomics and proteomics plays an important role in vaccinology and has resulted in developing new veterinary vaccines and also improving the efficiency of current veterinary vaccines.”

— Anasuya Vemuri

HYDERABAD, TELANGANA, INDIA, October 12, 2017 /EINPresswire.com/ -- The potential of vaccines to improve efficiency of growth, provide immunity towards diseases, and to lower the rate of mortality has become a critical factor in prevention of diseases. Increased international movements and trade, increase in demand for preventive measures and improving Vaccine Technologies continuously fuel the market for Veterinary Vaccines. Europe is the leading market for veterinary vaccines closely followed by North America. Due to high susceptibility to diseases and heavy demand, Asia-Pacific is the fastest growing market for Veterinary Vaccines.

RI Technologies' Veterinary Vaccines market research report covers the Types of Veterinary Vaccines and the different Species for which Vaccines are available in the market. The Types of Veterinary Vaccines covered include Live Attenuated, Inactivated, Recombinant and Other (Conjugate Vaccines, DNA Vaccines, Toxoids etc). The Species include Bovine, Porcine, Poultry, Canine & Feline, Ovine & Caprine and Other (Equine, Fish, Wild Animals etc.). The study includes estimations and predictions for the total global Veterinary Vaccines market and also key regional markets including North America, Europe, Asia-Pacific Latin America, Middle East and Rest of World. Business profiles of 12 major companies are discussed in the report. The report serves as a guide to global Veterinary Vaccines industry, covering more than 360 companies that are engaged in the development and supply of Veterinary Vaccines. Compilation of Worldwide Patents and Research related to Veterinary Vaccines Market size is also provided. Information related to recent product releases, product developments, partnerships, collaborations, and mergers and acquisitions is also covered in the report. Exclusive graphically illustrated exhibits 116 complement the text.

The global Veterinary Vaccines market is rapidly growing at a CAGR of more than 6.6%. Application of genomics and proteomics plays an important role in vaccinology and has resulted in developing new vaccines and also improving the efficiency of present vaccines. Subunit vaccines, recombinant vaccines, DNA vaccines and vectored vaccines are rapidly gaining scientific and public acceptance as the new generation of vaccines and are considered as alternatives to current conventional vaccines. Almost 2000 of the licensed vaccines in the US are killed or live attenuated bacteria or viruses. Development in molecular biology, immunology and genetics has enhanced the production of safer and more effective vaccines. It is also pivotal to formulate and deliver these vaccines appropriately to maximize its potential in pathogenesis and vaccinology. Immunological research in animal species and means of stimulation of immunity should be intensified greatly. This is made easier with the access to genome sequences of major species such as cattle, dogs, pigs etc. Research on adjuvants which are capable of stimulating innate immunity is also of major importance. The methods of vaccine administration are an important aspect in veterinary vaccinology, especially in the case of vaccines for wild and domestic animals. These animals are not only hosts to identified diseases, but also for potential diseases that have not been identified yet. Certain vaccines are meant only for the preservation of endangered species. The plant-based vaccine technology works by making plants the production centers of the requisite proteins to develop the vaccines. Thus, these plants become the veritable storehouses for vaccine antigens that include bacteria, viruses and parasites. 

Veterinary Vaccines report is an ideal research tool providing strategic business intelligence to the corporate sector. This report may help strategists, investors, laboratories, pharmaceutical companies, contract research organizations, biotechnology companies and drug approval authorities in--
 Gauging Competitive Intelligence
 Identifying Key Growth Areas and Opportunities
 Understanding Geographic Relevance to Product
 Knowing Regional Market Sizes and Growth Opportunities and Restraints
 Keeping Tab on Emerging Technologies
 Equity Analysis
 Tapping New Markets

Analytics and data presented in this report pertain to several parameters such as –
 Global and Regional Market Sizes, Market Shares, Market Trends
 Product (Global and Regional) Market Sizes, Market Shares, Market Trends
 Technology Trends
 Corporate Intelligence
 Key Companies by Sales, Brands, Products
 Consumer Behavioral Patterns
 Other Strategic Business Affecting Data


RI Technologies believes in pure research that will trigger action for immediate customer needs rather than plain reporting of data. 

Request Sample Pages | Veterinary Vaccines Market Research Report is now available at 25% discount | Order Now!

For more information, please Contact Us at contactus@researchimpact.com

About RI Technologies

Celebrating a Decade of Excellence in Market Research!

RI Technologies is a premier source of market research in Biotechnology and Healthcare sectors. Emphasis is on factual insights and forecasts with maximum global coverage. RI Technologies is constantly monitoring the biotechnology and Healthcare sectors, tracking market trends, and forecasting industry based on specialized analysis. RIT strives to provide market insight reports that empower customers with enlightening critical business information. The company’s Market Insight Reports will help you focus attention on your objectives. The strategic market information tables, graphically represented, will aid your research needs and help in forecasting, and gearing up to the future, armed with qualitative research. This will significantly reduce risks of new product development and give a global vision and perspective to your product.

RI Technologies’ Market Insight Reports are designed and compiled to customer requirements. These reports will help in learning strategic information, checking out the competition, and gaining meaningful insights into the market. Preparedness for any market entry helps in winning and reduces chances of losing. Benchmarks can be created to measure growth and progress. You can gauge how well you are doing, raise your own standards, and lead your company to sustained growth. 

Explore Market Opportunities, Gain Market Insights!

Anasuya Vemuri
RI Technologies
+91 9676994272

Apoptosis - The “New and Exploding” Area of Biological Research

Caspase Independent Cell Death (CICD), a novel method, triggers death of cancerous cells by alerting the human immune system by releasing inflammatory proteins.

Shortcomings in apoptosis can lead to cancer, auto immune diseases and viral infections while excessive apoptosis can cause or worsen neurodegenerative ailments, AIDS and ischemic diseases.”

— Anasuya Vemuri

HYDERABAD, TELANGANA, INDIA, September 7, 2017 /EINPresswire.com/ -- Apoptosis market research report by RI Technologies gives an insight into Apoptosis Mechanism, by Molecular Pathways – Caspase Activators and Inhibitors, Protease/Proteasome Inhibitors, Bcl-2 Modulators and p53 Modulators. The study also focuses on major diseases for which the treatment is based on apoptosis comprising Cancer, Neurodegenerative Diseases, Cardiovascular Diseases and other apoptosis based diseases including HIV infection, Organ Transplant Rejection and MODS. Business profiles of 47 major companies are discussed in the report. The report serves as a guide to global apoptosis market, as it covers more than 550 companies that are engaged in apoptosis research, testing and supply of products and services. Major Contract Research Organizations and Universities serving apoptosis market are also covered in the Corporate Directory section of this report. Information related product developments, partnerships, collaborations, and mergers and acquisitions are also covered in the report. Compilation of Worldwide Patents and Research related to Apoptosis is provided.

Over the past few years, availability of apoptosis related products (drugs, kits and reagents) has increased enormously. Global market for apoptosis related products is expected to grow at a high CAGR of about 30% through 2022, and the high growth is owing to increasing evidence of the role of apoptosis in mechanism of action for large number of diseases such as Cancer; Neurodegenerative Diseases including Alzheimer's, Parkinson's, Multiple Sclerosis and Rheumatoid Arthritis; Cardiovascular Disease; and other apoptosis based diseases including organ transplant rejection and HIV infection. Cancer research has delivered outstanding progress in understanding the biology and genomics of cancer, in the last decade. Foremost of these progress areas is the recognition of apoptosis and its regulatory genes that have an effect on melanoma. In return, other oncogenical changes stimulate apoptosis and override apoptosis during multistage carcinogenesis by making selective pressures. Apoptosis associates cancer therapeutics with cancer genetics by providing conceptual structure, as well as similar changes that suppress apoptosis during tumor development.

The growth of multi-cellular organic structures and their protection hinges upon a complex interaction between the cells constituting the organism. The process, now and then’ even takes the form of selfless actions of individual cells in support of the living being in its entirety. During growth more number of cells than necessary are generated, which ultimately experience programmed cell death and thus, facilitates in carving out several organs and tissues.
A predominantly educative illustration for connotation of programmed cell death during the process of growth of an animal is the creation of free and separate numbers of cells by death of cells in enormous numbers in the ‘inter-digital Mesenchymal tissue’ Other examples of programmed cell death, include the growth of the brain and the reproductive organs. During the growth of brain at least fifty percent of neurons generated initially will die in subsequent stages, when the growth of the brain is complete. Moreover, cells of a mature living organism regularly experience cell death as part of their functioning and the homeostasis or equilibrium is maintained in terms of constant number of cells through their propagation. 

Taking into account all aspects, it can be stated that as apoptotic processes play a vital role in the growth, differentiation, propagation, homeostasis, controlling and working of the immune system, elimination of defective and dangerous cells, they have comprehensive biological significance. Any dysfunction or defective management of apoptotic process manifests in a range of pathological conditions. Shortcomings in apoptosis can lead to development of cancer, auto immune diseases and spread of viral infections. On the other hand, excessive apoptosis can cause or worsen ‘neurodegenerative’ ailments, AIDS and ischemic diseases.

Apoptosis report is an ideal research tool providing strategic business intelligence to the corporate sector. This report may help strategists, investors, laboratories, pharmaceutical companies, contract research organizations, biotechnology companies and drug approval authorities in--
 Gauging Competitive Intelligence
 Identifying Key Growth Areas and Opportunities
 Understanding Geographic Relevance to Product
 Knowing Regional Market Sizes and Growth Opportunities and Restraints
 Keeping Tab on Emerging Technologies
 Equity Analysis
 Tapping New Markets

Analytics and data presented in this report pertain to several parameters such as –
 Global and Regional Market Sizes, Market Shares, Market Trends
 Product (Global and Regional) Market Sizes, Market Shares, Market Trends
 Technology Trends
 Corporate Intelligence
 Key Companies by Sales, Brands, Products
 Consumer Behavioral Patterns
 Other Strategic Business Affecting Data


RI Technologies believes in pure research that will trigger action for immediate customer needs rather than plain reporting of data. 

Request Sample Pages | Apoptosis Market Research Report is now available at 25% discount | Order Now!

For more information, please Contact Us at contactus@researchimpact.com

About RI Technologies

Celebrating a Decade of Excellence in Market Research!

Research Impact Technologies (RI Technologies, RIT) is a premier source of market research in Biotechnology and Healthcare sectors. Emphasis is on factual insights and forecasts with maximum global coverage. RI Technologies is constantly monitoring the biotechnology and Healthcare sectors, tracking market trends, and forecasting industry based on specialized analysis. RIT strives to provide market insight reports that empower customers with enlightening critical business information. The company’s Market Insight Reports will help you focus attention on your objectives. The strategic market information tables, graphically represented, will aid your research needs and help in forecasting, and gearing up to the future, armed with qualitative research. This will significantly reduce risks of new product development and give a global vision and perspective to your product.

RI Technologies’ Market Insight Reports are designed and compiled to customer requirements. These reports will help in learning strategic information, checking out the competition, and gaining meaningful insights into the market. Preparedness for any market entry helps in winning and reduces chances of losing. Benchmarks can be created to measure growth and progress. You can gauge how well you are doing, raise your own standards, and lead your company to sustained growth. 

Explore Market Opportunities, Gain Market Insights!

Anasuya Vemuri
RI Technologies
+91 9676994272

Glucosamine - Market Consolidation on the Rise as Demand Increases

Demand for dietary supplements is growing stronger, crossing demographic lines and expanding market opportunities for companies across a wide range of products.

Introduction of combination products with collagen, glucosamine and chondroitin are undercutting sales for single glucosamine dietary supplements, while vegetarian versions open up to a wider market.”

— Anasuya Vemuri

HYDERABAD, TELANGANA, INDIA, August 3, 2017 /EINPresswire.com/ -- RI Technologies' exclusive market update on Glucosamine analyzes the market by Type and Application at global level and for each of the geographic regions - North America, Europe, China, Asia-Pacific, and Rest of World. The Glucosamine market is segmented by Type into Glucosamine Sulphate, Glucosamine HCl and N-Acetyl-Glucosamine; and by Application into Nutraceutical/Pharmaceutical, Feed Additives, and Food Ingredients. Global market by Volume in Metric Tons and Value in US$ is also included. Business profiles of 42 major companies are discussed in the report. Glucosamine market size serves as a guide to Glucosamine industry covering more than 400 companies that are engaged in Glucosamine R&D, processing, production, and distribution. Information related to recent product releases, product developments, partnerships, collaborations, mergers and acquisitions, ethical issues, regulatory affairs, and other areas of concern is also covered in the report. Compilation of Worldwide Patents and Research related to Glucosamine market is also provided. Historic, Current and Future markets are graphically illustrated by 215 exclusive exhibits for all geographic regions.

Glucosamine supplements could restore the Glucosamine levels in the body and also repair joints that are destroyed by osteoarthritis or other wounds. Glucosamine based products were classified as nutraceuticals in most countries worldwide. But now a number of countries (especially Europe) are permitting glucosamine products to be registered as pharmaceuticals. Products sold as drugs need to be approved by national medicines agencies, whereas nutraceuticals in general are governed by much less demanding food regulations. As a result of the US anti-dumping action against shrimp shells from India and the EU ban on seafood imports from China, there was a steep rise in the price of Glucosamine. But since the uplift of the ban price of glucosamine has more or less stabilized. Change in the status of Glucosamine from drug to food has led to the market being opened up. Since its entrance on the food market, glucosamine has tripled in sales. The recommended dose of glucosamine is 1,500mg. Putting that level into food may cause an issue, due to its taste and also the expense. The introduction of combination products such as Vitabiotics' Jointace [supplement] with collagen, glucosamine and chondroitin are undercutting sales for single glucosamine dietary supplements on the market. Glucosamine is traditionally sourced from shellfish, but one of the interesting areas in this field is the launch of vegetarian versions. Clearly, this opens up the supplement to a wider target market, and in addition prices are relatively stable compared to shellfish.

Glucosamine report is an ideal research tool providing strategic business intelligence to the corporate sector. This report may help strategists, investors, laboratories, pharmaceutical companies, contract research organizations, biotechnology companies and drug approval authorities in--
 Gauging Competitive Intelligence
 Identifying Key Growth Areas and Opportunities
 Understanding Geographic Relevance to Product
 Knowing Regional Market Sizes and Growth Opportunities and Restraints
 Keeping Tab on Emerging Technologies
 Equity Analysis
 Tapping New Markets

Analytics and data presented in this report pertain to several parameters such as –
 Global and Regional Market Sizes, Market Shares, Market Trends
 Product (Global and Regional) Market Sizes, Market Shares, Market Trends
 Technology Trends
 Corporate Intelligence
 Key Companies by Sales, Brands, Products
 Consumer Behavioral Patterns
 Other Strategic Business Affecting Data


RI Technologies believes in pure research that will trigger action for immediate customer needs rather than plain reporting of data. 

Request Sample Pages | Glucosamine Market Research Report is now available at 25% discount | Order Now!

For more information, please Contact Us at contactus@researchimpact.com



About RI Technologies

Celebrating a Decade of Excellence in Market Research!

Research Impact Technologies (RI Technologies, RIT) is a premier source of market research in Biotechnology and Healthcare sectors. Emphasis is on factual insights and forecasts with maximum global coverage. RI Technologies is constantly monitoring the biotechnology and Healthcare sectors, tracking market trends, and forecasting industry based on specialized analysis. RIT strives to provide market insight reports that empower customers with enlightening critical business information. The company’s Market Insight Reports will help you focus attention on your objectives. The strategic market information tables, graphically represented, will aid your research needs and help in forecasting, and gearing up to the future, armed with qualitative research. This will significantly reduce risks of new product development and give a global vision and perspective to your product.

RI Technologies’ Market Insight Reports are designed and compiled to customer requirements. These reports will help in learning strategic information, checking out the competition, and gaining meaningful insights into the market. Preparedness for any market entry helps in winning and reduces chances of losing. Benchmarks can be created to measure growth and progress. You can gauge how well you are doing, raise your own standards, and lead your company to sustained growth. 

Explore Market Opportunities, Gain Market Insights!

Anasuya Vemuri
RI Technologies
+91 9676994272

Liposomes - Successful Drug Carriers - Novel Applications Galore for the Future

Liposomes in drug delivery have proved their mettle. Improved efficacy, while minimizing toxicity, will open up new markets for pharma/drug delivery companies. 

Environmentally sensitive liposomes, that respond to external stimuli such as pH, heat and light and can reach specific target sites within the layers of skin, hold great promise for research.”

— Anasuya Vemuri

HYDERABAD, TELANGANA, INDIA, July 6, 2017 /EINPresswire.com/ -- RI Technologies' market insight report on Liposomes gives an insight into global Liposomes market, which is projected to reach about US$ 26.2 billion by 2022. Today, the possible use of flexible liposomes and its advantages due to the fact that it administers actives to the living cells is under study. Modern technology in pharmaceuticals has helped in the detection of individual diseases. Now it is also possible to combine diagnostics and therapy to cure the disease instead of just treating the symptoms. Analysts expect that by 2030 personalized therapeutics would contribute to at least 25% of the market share. Research has proved commercial feasibility and medical effectiveness of using lipid-based technologies for delivery of different types of drugs. Adequate flexibility is offered by these technologies so that they may be used to administer drugs through pulmonary route, oral route, intravenous or parenteral route, or simply in topical applications.

The report provides market analytics by application, and by therapeutic area. The market is divided by Application into Therapeutic, Cosmetic and Other; and by Therapeutics into Antifungal, Anticancer, Ophthalmic and Others. The study also provides information regarding products and technologies in the field of Liposomes. Business profiles of 41 major companies are discussed in the report. The report covers more than 370 companies that are engaged in Liposomes research and supply of products and/or services. Compilation of Worldwide Patents and Research related to Liposomes is also provided. Projections and estimates are also illustrated by geographic regions encompassing North America, Europe, Asia-Pacific, and Rest of World with 99 exclusive graphically represented exhibits. Information related to recent product releases, product developments, partnerships, collaborations, mergers and acquisitions, and other areas of concern is also covered in the report.

Liposomes report is an ideal research tool providing strategic business intelligence to the corporate sector. This report may help strategists, investors, laboratories, pharmaceutical companies, contract research organizations, biotechnology companies and drug approval authorities in--
 Gauging Competitive Intelligence
 Identifying Key Growth Areas and Opportunities
 Understanding Geographic Relevance to Product
 Knowing Regional Market Sizes and Growth Opportunities and Restraints
 Keeping Tab on Emerging Technologies
 Equity Analysis
 Tapping New Markets

Analytics and data presented in this report pertain to several parameters such as –
 Global and Regional Market Sizes, Market Shares, Market Trends
 Product (Global and Regional) Market Sizes, Market Shares, Market Trends
 Technology Trends
 Corporate Intelligence
 Key Companies by Sales, Brands, Products
 Consumer Behavioral Patterns
 Other Strategic Business Affecting Data


RI Technologies believes in pure research that will trigger action for immediate customer needs rather than plain reporting of data. 


Request Sample Pages | Liposomes Market Research Report is now available at 25% discount | Order Now!

For more information, please Contact Us at contactus@researchimpact.com



About RI Technologies

Celebrating a Decade of Excellence in Market Research!

Research Impact Technologies (RI Technologies, RIT) is a premier source of market research in Biotechnology and Healthcare sectors. Emphasis is on factual insights and forecasts with maximum global coverage. RI Technologies is constantly monitoring the biotechnology and Healthcare sectors, tracking market trends, and forecasting industry based on specialized analysis. RIT strives to provide market insight reports that empower customers with enlightening critical business information. The company’s Market Insight Reports will help you focus attention on your objectives. The strategic market information tables, graphically represented, will aid your research needs and help in forecasting, and gearing up to the future, armed with qualitative research. This will significantly reduce risks of new product development and give a global vision and perspective to your product.

RI Technologies’ Market Insight Reports are designed and compiled to customer requirements. These reports will help in learning strategic information, checking out the competition, and gaining meaningful insights into the market. Preparedness for any market entry helps in winning and reduces chances of losing. Benchmarks can be created to measure growth and progress. You can gauge how well you are doing, raise your own standards, and lead your company to sustained growth. 

Explore Market Opportunities, Gain Market Insights!

Anasuya Vemuri
RI Technologies
+91 9676994272

Global High Throughput Screening Market Study-Technologies, Tools and Services

Global High Throughput Screening market is driven by advancements in HTS technologies and the increasing use of Bioinformatics/Lab-on-a-Chip/Microfluidics.

The success of Human Genome Project and latest findings in genomics and proteomics are creating an enormous market for HTS by identifying huge number of drug targets.”

— Anasuya Vemuri

HYDERABAD, TELANGANA, INDIA, June 7, 2017 /EINPresswire.com/ -- High Throughput Screening (HTS) report is an ideal research tool providing strategic business intelligence to the corporate sector. This report may help strategists, investors, laboratories, pharmaceutical companies, contract research organizations, biotechnology companies and drug approval authorities in--
 Gauging Competitive Intelligence
 Identifying Key Growth Areas and Opportunities
 Understanding Geographic Relevance to Product
 Knowing Regional Market Sizes and Growth Opportunities and Restraints
 Keeping Tab on Emerging Technologies
 Equity Analysis
 Tapping New Markets

Request Sample Pages | High Throughput Screening market research report is now available at 25% discount | Order Now!

For more information, please Contact Us at contactus@researchimpact.com

Celebrating a Decade of Excellence in Market Research!

RI Technologies believes in pure research that will trigger action for immediate customer needs rather than plain reporting of data. 

Currently, automation in HTS industry is in high gear. The companies are investing heavily in laboratory automation products such as HTS software, database systems, robotics arms and robot based workstations. The rising requirement of superior quality assays, better-output and enhanced drug discovery process is motivating scientists to keenly look out for strong and dependable assays by way of automation and use of modern techniques. Automation would enhance the quality and simplify the process of detecting leads, by realizing their properties perfectly. This is expected to emerge as a popular scenario in the years to come. Automation should be followed by humidity and temperature maintenance to render the desired results.

High Throughput Screening (HTS) Market research report emphasizes on both the technology and product segments of HTS in biotechnology and pharmaceutical application areas. The major technologies analyzed include Ultra High Throughput Screening, High Content Screening, Bioinformatics and Microfluidics/Lab-On-a-Chip; and the major product segments encompass HTS Services and HTS Tools. The global markets for Novel High Throughput Screening Products and Cell Based Assays are also discussed in the report. Markets covered for Microfluidics and Bioinformatics pertain to the applications of HTS. The report provides essential information including market data, segmentation, market size, key trends, M&A, product developments, industry forecasts, corporate intelligence, and other relevant information. The report lists more than 500 companies that are engaged in HTS services and/or production of HTS tools/instruments. Major Contract Research Organizations serving HTS industry are also covered in the corporate directory section of this report. Estimations and predictions are graphically represented by region, by technology and by product segment. Compilation of Worldwide Patents and Research related to High Throughput Screening is also provided. A global perspective is presented along with regional analysis covering the regions of North America, Europe, Asia-Pacific and Rest of World. The market is analyzed in US Dollars and includes 109 exclusive exhibits. High throughput screening market size, market review, market shares, and other key market results and trends are analyzed.

Strategic partnerships between pharmaceutical and biotechnology companies are the order of the day, and the trend is increasing globally. Another significant trend is the growing alliances among Pharma and Biotech companies and information technology companies such as Microsoft, IBM, Oracle, Sun, and Infosys, etc. The computer platforms generated by such companies help in managing and analyzing the huge amounts of data produced through High Throughput Screening (HTS) and other computational techniques. Effective R&D strategy involves efficient data management and implementation plans. The new technologies promise improved efficacy, decreased toxicity in patients, and reduced time frames and expenditures.

Changing business paradigms brought in by globalization and liberalization are making pharmaceutical companies change strategies for sustenance and growth. Many companies are venturing into HTS studies instead of going for alliances, to become self sufficient and reduce costs. The R&D wings are increasingly becoming target oriented to face the numerous challenges posed in the drug discovery and development industry. Global High through put screening market is especially driven by the advancements in HTS technologies and the increasing usage of innovative techniques such as Bioinformatics and Lab-on-a-Chip/Microfluidics. The success of Human Genome Project and latest findings in genomics and proteomics are creating an enormous market for HTS by identifying huge number of drug targets. Currently, automation in High through put screening Market industry is in high gear. The companies are investing heavily in laboratory automation products such as HTS software, database systems, robotics arms and robot based workstations.


About RI Technologies

Research Impact Technologies (RI Technologies, RIT) is a premier source of market research in Biotechnology and Healthcare sectors. Emphasis is on factual insights and forecasts with maximum global coverage. RI Technologies is constantly monitoring the biotechnology and Healthcare sectors, tracking market trends, and forecasting industry based on specialized analysis. RIT strives to provide market insight reports that empower customers with enlightening critical business information. The company’s Market Insight Reports will help you focus attention on your objectives. The strategic market information tables, graphically represented, will aid your research needs and help in forecasting, and gearing up to the future, armed with qualitative research. This will significantly reduce risks of new product development and give a global vision and perspective to your product.

RI Technologies’ Market Insight Reports are designed and compiled to customer requirements. These reports will help in learning strategic information, checking out the competition, and gaining meaningful insights into the market. Preparedness for any market entry helps in winning and reduces chances of losing. Benchmarks can be created to measure growth and progress. You can gauge how well you are doing, raise your own standards, and lead your company to sustained growth. Explore Market Opportunities, Gain Market Insights!

Anasuya Vemuri
RI Technologies
+91 9676994272
email us here

Drug Discovery Technologies and Dependence on ADME/TOX Screening

Find us on


May 4^th, 2017

The ADME/Tox screening market is the real hurdle in modern drug discovery technologies as animal models cannot be automated. Companies that develop state of art ADME/Tox screening products for human relevance will generate greater revenues due to the product demand in the market. Newer assays and new approaches to ADME/Tox screening are the demands of pharmaceutical companies. Combinatorial chemistry and HTS are enabling companies to test millions of drug compounds in lesser time frames.

Typically it takes about 10-12 years for a drug to see the light of the market. Of about 10,000 compounds that are screened, only about 2,000 pass through identification stage, of which about 10 enter preclinical testing and about 4.5 compounds to actual clinical testing, finally the most befitting one enters the market post government board approval. The procedure costs anything between US$500 million to US$1 billion.

The primary reason for drug removals from the market is attributed to liver injuries. Drug approvals come under serious question as there are drugs that are approved but then come under the gun due to their negative consequences. For example, fenfluramine has been in the market for many years and millions of patients have been subjected to this drug. It had to be withdrawn after serious aftereffects. Traditional toxicity studies could not predict troglitazone (an oral hypoglycemic agent), and Baycol, a statin, even though drug interaction studies could have determined some. Animal models depict human affinities better and can predict bone marrow and gastrointestinal toxicities. However, other toxicities cannot be well predicted. Rodents predict human toxicity the poorest, while dogs and monkeys show better results. But, mice studies cost less while dogs and monkeys incur huge expenditures and are restricted by availability.

What is Driving the ADME/TOX Market?

·      Global ADME/TOX market is mainly driven by the efforts of pharmaceutical and biotech companies for reducing time and cost of drug discovery.

·      ADME/Tox profiling of a drug candidate plays a key role in reducing clinical trials cost and time of drug launch in the market.

·      ADME/Tox assays eliminate compounds with lack of bioavailability, lower efficacy and toxicity in early stages, in order to save time and costs in expensive later stages of drug discovery.

·      Due to ethical issues and a growing trend towards decrease in using animals in clinical trials, there is a gradual decline in market for In vivo predictive technology.

·      Though In vivo accounts for about three- fourth of total ADME/Tox Technologies market currently, non-animal technologies - In vitro and In silico are projected to peg more than 70% of the market.

·      ADMET studies need to be deployed early stage and the technology should be scalable to high throughput formats. More and more companies are coming up with In silico approaches to ADMET, and are automating and integrating assays to HTS.

For More Information

Gain comprehensive information on Global ADME/TOX Technologies Market that includes insights into products and services used in the ADME/Tox market. Predictive technologies analyzed include In vivo, In vitro, and In silico. Related technologies such as High Throughput Screening (HTS), Laboratory Information Management System (LIMS), and cell based assays are also analyzed.   Market projections and estimates are illustrated by region and by technology. The report serves as a guide to ADME/Tox market, covering more than 350 companies that are engaged in ADME/Tox Market size/screening, products and services. Major Contract Research Organizations, Research Institutes and Universities serving the ADME/Tox market are also covered in the corporate directory section of this report. Information related to recent product releases, product developments, partnerships, collaborations, and mergers and acquisitions is covered in the report. Compilation of Worldwide Patents related to ADME/Tox Technologies is also provided. A global perspective is presented along with regional analysis covering the regions of North America, Europe, Asia-Pacific, Latin America, the Middle East and Africa with 93 exclusive graphically represented exhibits.

Why Buy this Report?

ADME/Tox Technologies report is an ideal research tool providing strategic business intelligence to the corporate sector. This report may help strategists, investors, laboratories, pharmaceutical companies, contract research organizations, companies and drug approval authorities in –

¬ Gauging Competitive Intelligence

¬ Identifying Key Growth Areas and Opportunities

¬ Understanding Geographic Relevance to Product

¬ Knowing Regional Market Sizes and Growth Opportunities and Restraints

¬ Keeping Tab on Emerging Technologies

¬ Equity Analysis

¬ Tapping New Markets

Request Sample Pages |  Related Reports |

Celebrating a Decade of Excellence in Market Research!

You can now avail 25% discount on the report. Free customization (100%) on report for Early Buyers.

About RI Technologies

Research Impact Technologies (RIT), www.researchimpact.com, is a premier source of market research in Biotechnology, Healthcare, and Life Science verticals. RIT has completed a decade of excellence in market research. The company has a wide portfolio of market research reports, country reports, company reports, and data exhibits. RIT’s expertise in custom research has helped several worldwide clients and the list of satisfied clients is growing!  The company’s reports have evolved over the years and are designed to help companies gain excellence and take their business to the next level. The company has become one of the most successful companies in this space and promises to continue to provide market-defining technologies, products, and services to its clients.

RI Technologies believes in pure research that will trigger action for immediate customer needs rather than plain reporting of data. The reports provide strategic information tools to the manufacturers, retailers, distributors, and suppliers that will help them to probe into and support critical business decisions. RI Technologies believes in broadening the value of market research obtained through several dedicated streams of information.  RI Technologies’ Market Insight Reports are designed and compiled to customer requirements. These reports will help in learning strategic information, checking out the competition, and gaining meaningful insights into the market. Preparedness for any market entry helps in winning and reduces chances of losing. Benchmarks can be created to measure growth and progress. You can gauge how well you are doing, raise your own standards, and lead your company to sustained growth.

Find out more about us: https://www.researchimpact.com/

Contact:
Satya Prasad

Tel: +91 9676994272

 Email: contactus@researchimpact.com